Vet. gyd. P. Pilipausko gydymo įmonė, IĮ

Company age: 33 y. 1 mo.

Update

Company overview

Company name Vet. gyd. P. Pilipausko gydymo įmonė, IĮ
Company code 169914369
Registered address Plungės r. sav., Nausodžio sen., Varkalių k., Beržų g. 8, LT-90105
Registration date 1993-08-31 Company age: 33 y. 1 mo.
Phone Phone
Email None
Website None
Company manager For registered members only Log in
Revenue (2025) 30,417 € +2% History
Profit (2025) 12,097 € -1% History
Number of employees 1 History
Managed vehicles 1 List
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Individual Enterprise
NACE activity Veterinary activities
Sector Darbdaviai
Ownership form Private without foreign capital

Download a detailed company report

Make confident decisions with all the information about Vet. gyd. P. Pilipausko gydymo įmonė, IĮ. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report

Description

This description was generated by artificial intelligence.
Vet. gyd. P. Pilipausko gydymo imone, II is an operational private Individual Enterprise registered in 1993. It operates under Lithuanian private ownership, with governance listed as CEO only, and is classified as a micro company in the employers sector. The company’s core activity is veterinary activities (EVRK code N.75.00.00). It is based at Beržu g. 8, Varkaliu k., Nausodžio sen., Plunges r. sav., Telšiu apskr., Lithuania.

Financially, the business remained profitable in the latest financial year. In 2025, revenue was EUR 30.4K, compared with EUR 29.7K in 2024 and EUR 32.0K in 2023. Net profit in 2025 was EUR 12.1K, after EUR 12.2K in 2024 and EUR 14.5K in 2023. Profit margin stood at 39.8% in 2025. Over the two-year period, revenue was slightly lower than in 2023, but it increased again in 2025 after a decline in 2024. The company’s staff size was stable at 2 average employees in 2023, 2024 and 2025, and remained at 2 on average so far in 2026.